Steve Inouye
Mr. Inouye was appointed as the Chief Financial Officer for Conexeu Sciences in November 2023. Later, in April 2025, he was also appointed to the positions of Secretary and Treasurer to the Company’s board of directors. A seasoned financial executive of nearly 40 years, Steve’s career focus has naturally been upon accounting and tax management. However, he also provided strategic guidance to an array of both private and publicly held companies, where he served in pivotal senior leadership roles.
Spanning startup and small-cap public market sectors, Mr. Inouye holds a strong command of capital market advisory services. Therein, his expertise includes guidance for ‘go-public’ transactions where he has contributed to effective capital raising initiatives, which have fueled corporate growth. Steve’s veteran experience also encompasses both US- and Canadian-listed companies, guiding in their adherence to prevailing securities regulations and corporate governance. Although a generalist, Mr. Inouye’s greater focus has been devoted to companies operating in the biopharmaceutical, natural healing, and fitness industries.